SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+1.05%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$249M
AUM Growth
+$249M
(-25%)
Cap. Flow
-$78.1M
Cap. Flow
% of AUM
-31.36%
Top 10 Holdings %
Top 10 Hldgs %
61.55%
Holding
64
New
7
Increased
31
Reduced
6
Closed
11
Top Buys
| 1 |
Centene
CNC
|
$14.2M |
| 2 |
Disc Medicine
IRON
|
$11.2M |
| 3 |
Sanofi
SNY
|
$9.06M |
| 4 |
Edgewise Therapeutics
EWTX
|
$7.08M |
| 5 |
Maximus
MMS
|
$5.6M |
Top Sells
| 1 |
Icon
ICLR
|
$35.6M |
| 2 |
Zimmer Biomet
ZBH
|
$21.2M |
| 3 |
Labcorp
LH
|
$19.5M |
| 4 |
Teleflex
TFX
|
$14.9M |
| 5 |
Neurocrine Biosciences
NBIX
|
$10.9M |
Sector Composition
| 1 | Healthcare | 83.62% |
| 2 | Industrials | 15.44% |
| 3 | Technology | 0.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Zimmer Biomet
ZBH
$20.8B
| – | – |
-187,685
| Closed | -$21.2M |
|
|
VXRT
52
DELISTED
Vaxart
VXRT
| – | – |
-5,583,448
| Closed | -$2.27M |
|
|
53
Teleflex
TFX
$5.57B
| – | – |
-107,780
| Closed | -$14.9M |
|
54
Protara Therapeutics
TARA
$125M
| – | – |
-1,514,300
| Closed | -$6.45M |
|
|
55
Labcorp
LH
$22.8B
| – | – |
-83,873
| Closed | -$19.5M |
|
56
Ironwood Pharmaceuticals
IRWD
$201M
| – | – |
-1,017,616
| Closed | -$1.5M |
|
57
INmune Bio
INMB
$52.4M
| – | – |
0
| – | – |
|
58
Idexx Laboratories
IDXX
$50.7B
| – | – |
0
| – | – |
|
|
59
Icon
ICLR
$14B
| – | – |
-203,311
| Closed | -$35.6M |
|
60
Haemonetics
HAE
$2.57B
| – | – |
-133,966
| Closed | -$8.51M |
|
61
89bio
ETNB
$1.37B
| – | – |
-500,000
| Closed | -$3.64M |
|
62
Akero Therapeutics
AKRO
$3.65B
| – | – |
-85,000
| Closed | -$3.44M |
|
63
Soleno Therapeutics
SLNO
$3.56B
| – | – |
0
| – | – |
|
64
Praxis Precision Medicines
PRAX
$980M
| – | – |
-112,500
| Closed | -$4.26M |
|